---
title: Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis
nct_id: NCT04932616
overall_status: UNKNOWN
sponsor: Istanbul University - Cerrahpasa
study_type: OBSERVATIONAL
primary_condition: Multiple Sclerosis
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04932616.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04932616"
ct_last_update_post_date: 2021-06-21
last_seen_at: "2026-05-12T07:27:27.114Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis

**Official Title:** Use of the Functional Gait Assessment in Patients With Multiple Sclerosis: Examining Reliability Between Face-to-Face and Online Applications

**NCT ID:** [NCT04932616](https://clinicaltrials.gov/study/NCT04932616)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 32
- **Lead Sponsor:** Istanbul University - Cerrahpasa
- **Conditions:** Multiple Sclerosis
- **Start Date:** 2021-01-26
- **Completion Date:** 2021-08-01
- **CT.gov Last Update:** 2021-06-21

## Brief Summary

The aim of the study is to examine the reliability of the method by applying the Functional Gait Assessment in patients with Multiple Sclerosis via online video conferencing. For this purpose, walking of each patient to be included in the study; The evaluation results will be compared and the intra-rater reliability will be investigated by evaluating both face-to-face and online video conferencing methods. Since the Functional Gait Assessment is not available in Turkish, the scale will also be validated by adapting it to Turkish within the scope of the study.

## Detailed Description

As with all neurological diseases, it is important to use appropriate outcome measurements in the assessment of balance and gait disorders in patients with Multiple Sclerosis (MS), in order to determine the appropriate program for the patient in physiotherapy and rehabilitation applications, both face-to-face and through telerehabilitation. The scale recommended by a clinical practice guide developed with the support of the American Physiotherapy Association (APTA) and the Academy of Neurological Physiotherapy (ANPT) is the Functional Gait Assessment (FGA). According to this proposal, a Turkish version will be made within the scope of the study so that functional walking evaluation can be used in our country. A 2017 study on functional gait assessment and Multiple Sclerosis investigated the validity and sensitivity to changes in the original English version of the test in multiple sclerosis, and as a result, its validity was found for MS. Functional gait assessment does not have a reliability study for Multiple Sclerosis.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Having a definite diagnosis of MS of any clinical type according to the 2017 Mc Donalds criteria by a neurologist,
* 18 years and over
* Expanded Disability Status Scale (EDSS) score of 2,5-6
* Not having an attack within the last 30 days
* Voluntarily giving consent to participate in the study
* Absence of visual and auditory impairment for completion of assessments

For Tele-assessment:

* Having a walking area of at least 3 meters at home to evaluate walking
* Providing a care provider's supervision to ensure walking safety
* The patient or the caregiver can use the video conferencing software application from the phone or computer

Exclusion Criteria:

* Diagnosis of another neurological disease that affects the level of ambulation other than MS
* Receiving corticosteroid therapy within the last 1 month
* Limitation in range of motion of the lower extremities, which may affect standing and walking
* Pain that negatively affects walking in the lower extremity and lumbar area (etc., coxarthrosis, gonarthrosis, sciatica)
* Inability to stand up from a sitting position (Timed Up \& Go Test requirement)
```

## Arms

- **Face To Face (Clinic) Group Functional Gait Assessment** — Evaluations to be applied for the cultural adaptation and reliability study of the scale:

Functional Gait Assessment, Timed Up and Go Test, Four-Step Square Test, Timed 25-Foot Walk Test, 12-Item Multiple Sclerosis Walking Scale Berg Balance Scale
- **Tele- Assessment Group Functional Gait Assessment** — The evaluation to be applied for the tele-evaluation reliability study of the scale:

Functional Gait Assessment

## Primary Outcomes

- **Functional Gait Assessment** _(time frame: change from baseline at 15 day)_ — The Functional Gait Assessment is a test designed to assess balance during various walking tasks. This test is a modification of the Dynamic Gait Index to increase reliability and reduce the ceiling effect. This test, which consists of 10 items, evaluates dynamic balance skills such as walking at normal and different speeds, walking with horizontal and vertical head movements, turning quickly, walking over objects, toe-heel walking, walking backwards, walking with eyes closed, and climbing stairs. Each item is scored between 0-3 points; 0 indicates that he is unable to perform that skill or severe gait or balance disorder is observed while performing that skill, and 3 indicates that he has achieved that skill normally. Points 1 and 2 are scored for each task separately for specific situations. Items are added to score the FGA and the maximum total score is set as 30.

## Secondary Outcomes

- **Timed 25-Foot Walk Test** _(time frame: Baseline)_
- **Timed Up and Go Test** _(time frame: Baseline)_
- **Berg Balance Test** _(time frame: Baseline)_
- **The Four Square Step Test** _(time frame: Baseline)_
- **12-item Multiple Sclerosis Walking Scale** _(time frame: Baseline)_

## Locations (1)

- Memorial Sisli Hospital, Neurology Clinic, Istanbul, Sisli, Turkey (Türkiye) — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.memorial sisli hospital, neurology clinic|istanbul|sisli|turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04932616.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04932616*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*